Caricamento...
Effective Effectors: How T cells Access and Infiltrate the Central Nervous System
Several Phase II and III clinical trials have demonstrated that immunotherapy can induce objective responses in otherwise refractory malignancies in tumors outside the central nervous system. In large part, effector T cells mediate much of the antitumor efficacy in these trials, and potent antitumor...
Salvato in:
| Pubblicato in: | Pharmacol Ther |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7164682/ https://ncbi.nlm.nih.gov/pubmed/30557632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2018.12.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|